JeffreyJohnTosoianMD

Asst. Prof., Director of Translational Cancer Research, Urologic Oncology Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center

Dr. Tosoian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Michigan Medical CenterTranslational Cancer Research, Urologic Oncology, 2018 - 2021
Johns Hopkins UniversityResidency, Urology, 2012 - 2018
Johns Hopkins University School of MedicineClass of 2012, MD, MPH

PubMed

68 citations
Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.
Sasha C. Druskin, Jeffrey J. Tosoian, Allen Young, Sarah Collica, Arnav Srivastava
BJU International. 2018-04-01
63 citations
Prostate Health Index density improves detection of clinically significant prostate cancer.
Jeffrey J. Tosoian, Sasha C. Druskin, Darian Andreas, Patrick Mullane, Meera Chappidi
BJU International. 2017-12-01
29 citations
Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential
Eric A. Klein, Maria Santiago-Jimenez, Kasra Yousefi, Bruce Robbins, Edward M. Schaeffer
The Journal of Urology. 2017-01-01

Journal Articles

Evaluation of Patient- and Surgeon-Specific Variations in Patient-Reported Urinary Outcomes 3 Months After Radical Prostatectomy from a Statewide Improvement Collabora...
Gregory B Auffenberg, Jeffrey Tosoian, Richard Sarle, William K Johnston, Eduardo Kleer, Khurshid R Ghani, James Montie, JAMA Surgery
Association of Tumor-Infiltrating T-cell Density with Molecular Subtype, Racial Ancestry and Clinical Outcomes in Prostate Cancer
Tamara L Lotan, Edward M Schaeffer, Jeffrey J Tosoian, Scott A Tomlins, Nature

The Androgen Signaling Axis and Risk Stratification for High-Grade Prostate CancerMarch 2018
Risk Stratification in Active Surveillance: A Dynamic, Ever-Evolving PracticeFebruary 2018

Men with Prostate Cancer Live Longer if Relatives Had ItFebruary 10th, 2023
Drop in PSA Tied to Better Outcomes of Apalutamide Therapy in Prostate CancerJanuary 3rd, 2022
Surveillance for Prostate Cancer Is on the Rise -- Do Men Stick It Out?August 23rd, 2021
Join now to see all